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Highly conserved during evolution, the enzyme Ubc9 activates the small ubiquitin-like modifier (SUMO) prior to its covalent ligation to target
proteins. We have used mutations in the Drosophila Ubc9 (dUbc9) gene to understand Ubc9 functions in vivo. Loss-of-function mutations in
dUbc9 cause strong mitotic defects in larval hematopoietic tissues, an increase in the number of hematopoietic precursors in the lymph gland and
of mature blood cells in circulation, and an increase in the proportion of cyclin-B-positive cells. Some blood cells are polyploid and multinucleate,
exhibiting signs of genomic instability. We also observe an overabundance of highly differentiated blood cells (lamellocytes), normally not found
in healthy larvae. Lamellocytes in mutants are either free in circulation or recruited to form tumorous masses. Hematopoietic defects of dUbc9
mutants are strongly suppressed in the absence of the Rel/NF-nB-family transcription factors Dorsal and Dif or in the presence of a non-signaling
allele of Cactus, the InB protein in Drosophila. In the larval fat body, dUbc9 negatively regulates the expression of the antifungal peptide gene
drosomycin, which is constitutively expressed in dUbc9 mutants in the absence of immune challenge. dUbc9-mediated drosomycin expression
requires Dorsal and Dif. Together, our results support a role for dUbc9 in the negative regulation of the Drosophila NF-nB signaling pathways in
larval hematopoiesis and humoral immunity.
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Ubc9 was discovered in Saccharomyces cerevisiae based on
its sequence similarity to other known ubiquitin-conjugating
enzymes (Seufert et al., 1995). A loss of function ofUbc9 causes
an increase in the S- and M (B type)-phase cyclins, resulting in
an arrest of the cell cycle at the G2 or early M phase. This
cessation of the cell cycle causes an accumulation of large
budded cells with a single nucleus and replicated DNA. Ubc9
was also identified in a screen for DNA damage checkpoint
control in S. pombe (Al-Khodairy et al., 1995; Tanaka et al.,
1999). Although not directly involved in the checkpoint control,
Ubc9 (encoded by hus5) is required for the efficient recovery
from DNA damage or S-phase arrest, and for chromosome0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.08.008
* Corresponding author. Fax: +1 212 650 8585.
E-mail address: sgovind@ccny.cuny.edu (S. Govind).
1 These authors contributed equally to this work.segregation. Yeast mutants display severe impairment in growth
and exhibit a high frequency of failed mitosis. Further studies in
yeast revealed that unlike other E2 ubiquitin-conjugating
enzymes, Ubc9 is unable to form a thioester bond with ubiquitin;
instead it conjugates the ubiquitin-like protein SUMO/Smt3 to
specific targets in a yeast extract (Johnson and Blobel, 1997).
Vertebrate homologs of Ubc9 were subsequently identified
in many laboratories, showing that Ubc9 may interact with a
wide variety of cellular proteins, regulating cellular processes
such as cell division, protein trafficking, signal transduction,
and transcriptional regulation (Pichler and Melchoir, 2002;
Muller et al., 2000). Studies designed to identify biochemical
targets of Ubc9 highlighted a role for sumoylation in the
regulation of chromatin organization, gene expression, and
genome surveillance (Melchoir and Hengst, 2002; Muller et al.,
2004; Zhao et al., 2004).
While SUMO-1 is structurally similar to ubiquitin and
sumoylation and ubiquitination are enzymatically similar288 (2005) 60 – 72
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same protein can have opposite effects. For example, ubiquitin
or SUMO-1 can be directly conjugated to lysine residues 21
and 22 of mammalian InBa in reactions catalyzed by
activating enzymes Ubch5 and Ubc9, respectively (Scherer
et al., 1995; Desterro et al., 1998). InBa is a cytoplasmic
inhibitor of the transcription factor NF-nB. In unstimulated
cells, cytoplasmic NF-nB, complexed with InBa, remains
inactive. Activation of NF-nB is achieved by ubiquitination
and proteasome-mediated degradation of InBa, allowing NF-
nB translocation to the nucleus. However, when the same
lysine residues in InBa are conjugated to SUMO-1/Smt3,
ubiquitination is blocked, thereby stabilizing the cytoplasmic
pool of this protein. This increase in stabilization of InB
sequesters NF-nB in the cytoplasm, leading to a down-
regulation of the NF-nB pathway (Tashiro et al., 1997;
Desterro et al., 1998; Hay et al., 1999). Thus, while
ubiquitination targets proteins for degradation, SUMO-1
modification acts antagonistically to render proteins resistant
to degradation. Given that SUMO modification alters the
ability of proteins to interact with their partners, alters their
subcellular localization, and controls their stability, under-
standing the role of sumoylation in different cellular processes
is of fundamental importance in normal and diseased cells.
We are using Drosophila as a model system to understand
the functions of Ubc9 in vivo. An alignment of the Drosophila
Ubc9 (dUbc9) with its counterparts in yeast, C. elegans, and
humans shows that dUbc9 shares a higher level of structural
similarity with the human Ubc9 (84% identical) than with
either the C. elegans (76% identical) or yeast (35% identity)
proteins. Strikingly, expression of either human or Drosophila
Ubc9 can rescue an S. cerevisiae Ubc9ts mutant (Yasugi and
Howley, 1996; Joanisse et al., 1998). dUbc9, also called
semushi and lesswright, (lwr), has many biological functions.
For example, mutation in dUbc9 disrupts anterior segmentation
in embryogenesis by interfering with the nuclear uptake of the
homeodomain transcription factor Bicoid (Epps and Tanda,
1998). Mutants in dUbc9 also suppress the nodDTW (dominant
antimorphic allele of no distributive disjunction) phenotype,
implying a role in chromosome segregation during meiosis in
females (Apionishev et al., 2001). Biochemically, the SUMO-
1/Ubc9 pathways are conserved between flies and humans: (1)
dSmt3 and dUbc9 are coexpressed during development, (2)
dSmt3 can be processed and conjugated in human cells, and (3)
human transcription factor PML can be modified by dSmt3 in
Drosophila SL2 or human HeLa cells. Like their human
counterparts, dSmt3 and dUbc9 colocalize in nuclear foci
(Lehembre et al., 2000).
Drosophila Ubc9 was also identified in a yeast two-hybrid
screen for Dorsal-interacting proteins (Bhaskar et al., 2000).
Dorsal is one of three Drosophila Rel/NF-nB-family proteins
(Steward, 1989). The nuclear localization of Dorsal is
controlled by the Toll receptor. Toll activation leads to signal
transduction via Tube and Pelle, as well as the phosphorylation
and degradation of Cactus, the Drosophila InB protein (Kidd,
1992; Geisler et al., 1992). Components of the Toll–Dorsal
pathway were first identified as maternal-effect genes control-ling the development of the embryonic dorsal–ventral axis
(Steward, 1989; Drier and Steward, 1997; Govind, 1999; Roth,
2003). Although the precise mechanism underlying Cactus
degradation in the embryo is still unclear, in vivo studies
suggest that, like mammalian InBa, Cactus degradation is
regulated by Toll signal-dependent phosphorylation (Bergmann
et al., 1996; Fernandez et al., 2001). dUbc9 conjugates a
Drosophila SUMO/Smt3 to lysine 382 of Dorsal (Bhaskar et
al., 2002). Whether Cactus also serves as a sumoylation target
is not known.
In Drosophila, the NF-nB pathway regulates many biolo-
gical processes at different developmental stages (Govind,
1999). The Toll–Dorsal/Dif pathway activates transcription of
antifungal and antibacterial (Gram-positive) peptide genes in
the larval and adult fat body (Lemaitre et al., 1995, 1996; Meng
et al., 1999; Hoffmann and Reichhart, 2002). Dif (Dorsal-
related immunity factor) belongs to the NF-nB family (Ip et al.,
1993). The regulation of genes encoding antibacterial peptides
that kill Gram-negative bacteria (e.g., diptericin) is under the
control of Relish, the third Drosophila Rel/NF-nB protein
similar to the mammalian p100/p105 proteins (Dushay et al.,
1996). Relish activation is Toll-independent. Instead, the
intracellular Relish phosphorylation and activation are regulat-
ed by activities of Immune deficiency (Imd) pathway including
proteins of the IKK complex and the Dredd caspase (Lemaitre
et al., 1995; Silverman and Maniatis, 2001; Hoffmann and
Reichhart, 2002). This pathway is negatively regulated by the
ubiquitin proteasome system (Khush et al., 2002).
The Toll-InB pathway also contributes to proliferation of
blood cells (hemocytes) during normal larval hematopoiesis
and during the hematopoietic proliferation that accompanies
immune challenge (Qiu et al., 1998; Sorrentino et al., 2002,
2004). Unchallenged Drosophila larvae have two hemocyte
types in circulation: the plasmatocyte and the crystal cell, both
of which are specified and formed during embryonic stages
(Holz et al., 2003). More than 90% of all hemocytes in
circulation are plasmatocytes (Rizki and Rizki, 1984; Lanot et
al., 2001). Plasmatocytes are phagocytic cells, ridding the
larvae of microbial infections (Rizki and Rizki, 1984). The
remaining hemocytes in circulation (5% or less), the crystal
cells, carry prominent crystalline inclusions and, when activat-
ed, lyse and release their contents, melanizing target cells
(Rizki and Rizki, 1984; Lanot et al., 2001). Mutations that
upregulate the Toll pathway (loss-of-function mutations in
cactus, gain-of-function mutations in Toll, or overexpression of
Dorsal in larval hemocytes) result in overproliferation of
hemocytes, whereas mutations that downregulate the pathway
(loss-of-function in Toll, tube, or pelle) lead to a reduction in
the number of circulating hemocytes (Qiu et al., 1998).
Changes in hemocyte counts in mutations affecting either
dorsal or Dif are unremarkable (Sorrentino, 2003; Sorrentino et
al., 2004).
A third kind of hemocyte, the lamellocyte, appears in the
larval hemolymph only in response to infections by naturally
occurring endoparasitoid wasps and other foreign bodies. The
parasitoids constitute a major threat to the Drosophila
population in nature, as they hijack the larval body for their
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aggregate around a parasite egg to form a cellular capsule.
Parasite-induced lamellocyte differentiation in the lymph gland
is accompanied by a modest increase in the number of
plasmatocytes and crystal cells (Lanot et al., 2001; Sorrentino
et al., 2002). The encapsulated wasp egg is melanized.
Lamellocyte precursors are normally quiescent. However,
mutations that lead to the overproliferation of hemocytes
(loss-of-function cactus alleles, gain-of-function Toll alleles)
also result in constitutive differentiation of lamellocytes,
resulting in the encapsulation of self-tissue in the absence of
wasp infection (innate autoimmune response). Because of their
dark appearance, these capsules are called melanotic tumors
(Rizki and Rizki, 1984; Lemaitre et al., 1995; Govind, 1996;
Qiu et al., 1998).
In this study, we report that larvae carrying loss-of-function
mutations in dUbc9 show strong hematopoietic proliferation
and differentiation defects. Furthermore, the antifungal gene
drosomycin is constitutively active in developmentally delayed
dUbc9 mutants. Both constitutive humoral and cellular
immune defects are rescued by mutations in dorsal and Dif.
Our results suggest that dUbc9 contributes to the regulation of
both humoral immunity and hemocyte proliferation by acting
as a negative regulator of the Toll pathway.
Materials and methods
Fly culture and stocks
All three loss-of-function dUbc9 (lesswright, lwr) hypomorphic/amorphic
alleles (5, 4-3, and 14), in the following genetic context, yw; lwr FRT40A/
CyO y+ were obtained from S. Tanda (Ohio University). Complementation
analysis and molecular mapping of these alleles have been described previously
(Apionishev et al., 2001). The lwr mutants are lethal, and less than 5% of the
lwr4-3/lwr5 transheterozygote adults eclose. The other two heteroallelic
combinations in trans to lwr14 are lethal at the larval stages and do not yield
adults. Allele 5 (point mutation, R104H) was generated by EMS mutagenesis.
Allele 4-3 is a lethal revertant of the original P element insertion in lwr
(lwr5486), resulting in a 76-bp long insertion in the first non-coding exon. Allele
14 is a deficiency Df(2L)dUbc9–14 that was isolated as an excision and is
referred to in this paper as lwr14. This allele deletes a part of the first exon of
the lwr gene, and its 5V regulatory region extends into the next proximal gene,
shanti (Apionishev et al., 2001). These transheterozygous lwr combinations
also result in a delay in pupariation relative to heterozygous controls. When
comparing specific phenotypes between mutant and control animals, larvae
were obtained from short, 6-h egg lays. A UAS-lwr transgene rescues lethality
of lwr4-3/lwr5 animals (Apionishev et al., 2001).
Transgenic fly lines carrying GFP reporter constructs for expression of
antimicrobial peptides used to monitor expression of antimicrobial peptides
(drosomycin (drom), metchnikowin (metch), diptericin (dipt), attacin (att), and
cecropin (cec)) were obtained from B. Lemaitre and are described by
Ferrandon et al. (1998) and Tzou et al. (2000). They were crossed into lwr
backgrounds (allele combinations 4-3/5 and 5/14) using standard crosses.
Recombinant chromosomes carrying reporter transgenes were recovered in
males that were selected for the presence of w+ (red eye color) marker. Strains
carrying lwr and mutations in cact (alleles D13, E8, E10; Roth et al., 1991),
dl1 (Steward, 1989), Dif1 (Rutschmann et al., 2000), Df(2L)TW119 (Steward,
1989), and Df(2L)J4 (Meng et al., 1999) were made by meiotic recombination.
The Df(2L)TW119 and Df(2L)J4 deficiencies uncover both dl and Dif in
addition to other genes. The presence of specific mutations on the lwr
chromosome was evaluated by noncomplementation of viability or female
sterility in trans to a deficiency uncovering that gene or in a hetero-allelelic
combination. The recombinant chromosome was balanced with CyO y+ or CyOactin-GFP. Toll10b mwh e/TM6 Tb Ser/OR60 and y v hopTum-l/Basc stocks
were either recombined or crossed with the drom-GFP reporter.
Analysis of hematopoietic defects
The penetrance of melanotic tumors was determined by examination of
intact 10-day-old larvae through the cuticle. Hemocytes: circulating hemocyte
concentrations (CHC) were determined using the smear-based method
(Sorrentino et al., 2004). All hemocytes including lamellocytes and multinu-
cleate hemocytes, present in a known volume, were stained with a Hoechst
33258 nuclear dye (Molecular Probes) solution and counted. Mean CHC values
were derived from observations of ten or more animals. CHC and mean
lamellocyte percentages were compared using a modified Student’s t test (Crow
et al., 1960).
For determination of crystal cell number, 6-day-old third instar larvae were
placed in microfuge tubes containing water and then heated in a water bath at
70-C for 10 min. Melanized crystal cells in the last two posterior segments of
the larvae were counted as described in Duvic et al., 2002. The Black cells
mutation affects crystal cell development causing their melanization in vivo
(Rizki et al., 1985). Crystal cells were also quantified in hemolymph smears of
lwr4-3 Bc/lwr14 and lwr4-3 Bc/lwr5 animals. Overexpression of lwr in crystal
cells was achieved by crossing flies bearing the UAS-lwr transgene with those
carrying lz-GAL4 driver (Brand and Perrimon, 1993; Lebestky et al., 2000).
Mean values of crystal cell number for the experimental and control classes
were compared using the Student’s t test (Crow et al., 1960).
Lymph gland: to analyze hemocyte and lymph gland morphologies,
samples were stained with Hoechst 33258. Antibody staining: a monoclonal
antibody against the Drosophila Cyclin B protein (F2F4, Developmental
Studies Hybridoma Bank, University of Iowa) was incubated on hemocyte
smears and lymph glands from control and mutant animals using standard
protocols (Qiu et al., 1998; Sullivan et al., 2000). Bound antibodies were
visualized by fluorescently tagged secondary (FITC) antibodies (Fisher).
Stained samples were counterstained with the nuclear dye TOTO-3 (1:100 of
original stock, Molecular Probes) and with Alexa-labeled phalloidin (1:40 of
original stock, Molecular Probes; phalloidin binds to filamentous actin).
Hemocytes in circulation (smears) staining positively with the anti-Cyclin B
antibody in multiple independently processed-samples were hand-counted. A
Radiance 2000-KR3 Confocal Microscope (Biorad) or Zeiss Axioplan 2
equipped with fluorescence optics was used for imaging results. Data were
processed with Adobe Illustrator software.
Rescue UAS-GAL4 binary method of gene expression (Brand and
Perrimon, 1993) was used to rescue the mutant phenotypes. The Collagen
(Cg) promoter is transcriptionally active in embryonic and larval fat body and
hemocytes (Asha et al., 2003). Because of the coincidence of this expression
pattern and the phenotypes of interest in the lwr mutants, we used the Cg-GAL4
driver to express the wild-type (UAS-lwrwt) transgene. The Cg-GAL4 insert
was recombined with the lwr5 chromosome. The yellow ( y) mutation was
recombined with the w UAS-lwrwt chromosome. To determine if the expression
of UAS-lwrwt transgene will rescue the phenotypes observed in lwr4-3/lwr5
animals, we set up a cross of yw/yw; lwr5 Cg-GAL4/CyO y+ females and yw
UAS-lwrwt/Y; lwr4-3 drom-GFP/CyO y+ males and monitored three phenotypes
in mutant males (who do not carry the UAS-lwrwt transgene) and their sisters
(who carry and express the UAS-lwrwt transgene). Larvae of both these classes
have yellow mouth hooks (YMH). Sex type was determined by differences in
gonadal structures. Their heterozygous (black mouth hook) siblings served as
control groups. Animals from 6-h egg-lays at 26-C were monitored for (a) time
of pupariation, (b) extent of drom-GFP expression in fat body, and (c)
penetrance of melanotic tumors, from day 4 to 8 after egg lay.
Analysis of transcriptional activity
Transcriptional activity in vivo of the drom-GFP promoter was analyzed,
without or with immune challenge with E. coli, under a Leica stereomicroscope
equipped with GFP-compatible fluorescence. Immune challenge was admin-
istered with a fine glass needle which was used to puncture the dorsal, posterior
region of the larval body. Challenged larvae were allowed to recover on normal
fly food for 6 h, by which time a wound-healing reaction occurs and the drom-
GFP reporter is strongly expressed.
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the appropriate genotypes and equivalent developmental stage were isolated
in batches of 20 animals. Isolation of total RNA, blotting, and hybridization
were performed as described (Andres and Thummel, 1994). Probes for
antimicrobial genes were made by random prime labeling of PCR products
generated from w1118 genomic DNA. Primers (Sigma Genosys) used for
amplification of each probe deduced from the coding regions of the respective
genes are as follows: drosomycin (5VCAAACAGAAATCATTTACC-
AAGCTCC3V and 5VGCTTTTCAGAACGTTCATGC3V) and cecropin
A1 (5VACAACATCTTCGTTTTCGTCGCTCTC3V and 5VACCTCG-
GGCAGTTGCGGCGAC3V). PCR products were gel-isolated and purified
using a Qiaquick purification kit (Qiagen, Inc.). Approximately 25 ng of
purified PCR products was used in Rediprime II (Amersham) labeling
reactions. Experimental hybridizations were performed; blots were
then stripped and rehybridized with rp49. Relative signal obtained for
each lane was normalized to its respective rp49 signal. The resulting
normalized data were standardized to the signal obtained for the bacterially
induced control lane, set to 100, essentially as described in Lemaitre et al.
(1996). Similarly, the resulting normalized data were standardized to
the signal obtained for the uninduced control lane, set to 1. Quantifi-
cation of hybridization signal was performed using a Biostorm Phos-
phoimager (Molecular Dynamics) and ImageQuant 4.2 Software (Molecular
Dynamics).
Results
Constitutive proliferation and differentiation of hematopoietic
tissue in lwr mutants
Loss of function in lwr results in hemocyte overprolifera-
tion and occurrence of melanotic tumors (Figs. 1A–C; TableFig. 1. Hematopoietic defects in lesswright larvae. (A) lwr4-3/lwr14 (no tumors) and
from lwr4-3/lwr5 larva is composed largely of lamellocytes. (D–H) Hemocytes f
abundance, and morphology of mutant hemocytes. L: lamellocytes in circulation. P:
and lwr4-3/lwr5 hemocytes at higher magnification. Backgrounds with the lwr4-3
abnormally large hemocytes in panel (I) with fragmented Hoechst-positive material1, plus Supplementary data). In order to characterize the
nature and extent of lwr-induced hematopoietic defects, we
studied phenotypes of hemocytes in circulation and in the
lymph gland from homozygous and transheterozygous lwr
larvae. We found that, while all three heteroallelic combina-
tions show hematopoietic defects, the nature of specific
defects is dependent on the allele combination. While more
than 90% of lwr4-3/lwr5 and lwr5/lwr14 larvae have melanotic
tumors, only about 20% of the lwr4-3/lwr14 larvae show this
phenotype (Figs. 1A, B; 3A and Table 1). Tumors are
surrounded by lamellocytes (Fig. 1C).
We then compared concentration of circulating hemocytes
(CHC, hemocytes/Al) and lamellocyte percentages in hemo-
lymph samples from mutant larvae at days 4, 6, and 8 after
egg lay with hemolymph samples from 4-day-old heterozy-
gous siblings. Four days after egg lay, when development of
mutants is still comparable to that of their heterozygous
siblings, CHCs and lamellocyte percentages in lwr4-3/lwr5
and lwr5/lwr14 backgrounds are significantly higher than the
corresponding values of heterozygous controls (Figs. 1D–F;
Supplementary Tables 1.1, 1.2). The third class of hetero-
allelic lwr4-3/lwr14 animals that exhibits a low incidence of
melanotic tumors (Table 1) shows high lamellocyte percen-
tages, but their mean CHC value is within control range
(Supplementary Tables 1.1, 1.2).
Six days after egg lay, CHC continues to increase in
lwr4-3/lwr5 animals, although a further increase is not observed(B) lwr4-3/lwr5 larvae 8–10 days after egg lay. (C) Melanized capsule dissected
rom lwr4-3/+ (D), or lwr4-3/lwr5 (E, F) animals to show differences in size,
plasmatocytes in circulation. (G) lwr4-3/lwr14, (H) lwr4-3/lwr5, (I) lwr4-3/lwr14
allele show presence of multinucleate hemocytes (labeled M). Also notice
. Scale bars: C = 150 Am, D–F = 50 Am.
Table 1
Penetrance of the melanotic tumor phenotype in single, double and triple mutants
Genes affected Genotype Total #
of animals
Animals with
melanotic tumors
Melanotic tumor
penetrance (%)
lwr lwr4-3/lwr5 121 115 95.0
lwr lwr5/lwr14 121 110 90.9
lwr lwr4-3/lwr14 141 28 19.9
lwr dl C3 lwr4-3 Df(2L)J4/lwr5 dl1 125 23 18.4
lwr dl C3 lwr4-3 Df(2L)TW119/lwr5 dl1 115 3 2.6
lwr Dif C3 lwr4-3 Df(2L)J4/lwr5 Dif1 110 104 94.5
lwr Dif C3 lwr4-3 Df(2L)TW119/lwr5 Dif1 122 83 68.0
lwr dl Dif C3 lwr4-3 Df(2L)TW119/lwr5 Df(2L)J4 138 2 1.5
lwr cactE10 C3 lwr4-3 cactE8/lwr5 cactE10 101 4 4
dl Dif Df(2L)TW119/Df(2L)J4 >100 0 0
dl Df(2L)TW119/dl1 >100 0 0
Dif Df(2L)TW119/Dif1 >100 0 0
cactE10 cactD13/cactE10 >100 0 0
Genetic backgrounds are indicated. The direction of crosses had no effect on outcome. Phenotype was scored in 9- to 10-day-old larvae. In genetic backgrounds
where suppression of the tumor phenotype is observed, the size of tumors is significantly reduced as compared to lwr mutants at the same age (see Fig. 3). C3 refers
to the presence of the drom-GFP transgene.
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no significant changes in CHC are observed in lwr4-3/lwr14
larvae at day 6. Lamellocytes continue to be present at higher
than normal levels in animals of both these genetic back-
grounds (Supplementary Table 1.2).
Unusual hemocytes
In addition to an overabundance of apparently normal
plasmatocytes and lamellocytes, hemocytes with unusual
nuclear morphology are present in two of the three hetero-
allelic lwr combinations. More than 6% of the lwr4-3/lwr14
hemocytes are multinucleate (Fig. 1G). Such multinucleate
hemocytes are less frequently observed in lwr4-3/lwr5 animals
(Fig. 1H), although like their lwr4-3/lwr14 counterparts, they
exhibit abnormally large hemocytes with one or more large
and several additional Hoechst-positive structures (Fig. 1I).
We did not observe a significant multinucleate hemocyte
population in lwr5/lwr14 (data not shown).
Effects on the crystal cell population
To examine if lwr mutation affects the crystal cell number,
we counted the number of crystal cells in the posterior larval
segments of mutant and heterozygous sibling animals. We
found that there is a significant reduction in crystal cells in all
three heteroallelic combinations. The strongest effect (more
than 20-fold reduction) is observed in the lwr5/lwr14
background, whereas modest effects (5- to 10-fold) are seen
in lwr4-3/lwr5 and lwr4-3/lwr14 (P < 0.05; Supplementary
Table 1.3). We confirmed these results in a different assay
where the proportion of blackened crystal cells within smears
of mutants were compared to controls. These results also
showed a statistically significant reduction in the crystal cell
population in lesswright mutant as compared to controls,
lwr/+ (P < 0.05; Supplementary Table 1.3). To test if
dUbc9 over-expression can drive the production of additional
crystal cells, we expressed lesswright in crystal cell pre-
cursors using the lz-GAL4 driver. However, this over-expression did not lead to a significant change in crystal cell
number (P > 0.05; Supplementary Table 1.3).
Effects on lymph gland hemocyte populations
Hematopoietic defects in lwr mutants are not restricted to
circulating hemocytes. Hemocytes of the mutant lymph
glands exhibit the unusual nuclear morphology observed in
hemocytes in circulation (Figs. 2A, B). To examine if lwr
affects mitosis, we stained lymph glands and hemocytes in
circulation with anti-cyclin B antibody. Cells were counter-
stained with the fluorescent nuclear dye TOTO-3. Glands
were also stained with Alexa-labeled phalloidin to visualize
their general organization. We found that the proportion of
cyclin-B-positive hemocytes in the anterior and posterior
lobes of mutant glands is higher than in their control
counterparts (Figs. 2C, D). Similarly, the proportion of
cyclin-B-positive circulating hemocytes is higher in mutant
hemolymph, where more than 40% of the cells exhibit
positive staining [lwr4-3/lwr4-3: 44.0% (n = 243), lwr5/lwr5:
56.0% (n = 255)]. In contrast, less than 5% of the control
samples [(lwr4-3/CyO y+: 4.8% (n = 63); lwr5/CyO y+ 3.5%
(n = 58)] stain with anti-Cyclin B (Figs. 2E, F). These results
suggest that the dUbc9 enzyme controls mitosis in part by
controlling cyclin B levels during hemocyte development in
the Drosophila larva.
Suppression of hematopoietic defects by mutations in dorsal
and Dif
Since the Toll-Cactus signal transduction pathway has been
implicated in hemocyte proliferation (Qiu et al., 1998), we
examined if the hemocyte overproliferation defects in lwr
mutants are dependent on the presence of the Dorsal and/or
Dif proteins. We found that the removal of dl and Dif (which
are both uncovered by the deficiencies Df(2L)TW119 and
Df(2L)J4) resulted in the reduction in melanotic tumor
penetrance, CHC, and relative abundances of different
hemocyte types. Fewer than 2% of lwr Dif dl triple mutant
Fig. 2. Cyclin B staining of hematopoietic precursors and hemocytes of lwr
mutants. (A, B) Whole mount images of anterior lobes (AL) of lwr4-3/+ control
(A) and lwr4-3/lwr14 mutant (B) lymph glands. Notice the presence of larger
nuclei in mutant glands (white arrows). (C, D) Confocal images of lymph
glands from control (C, lwr4-3/+) and mutant (D, lwr4-3/lwr4-3) larvae stained
with anti-cyclin B and visualized with FITC-labeled secondary antibody
(green) and counterstained with fluorescent nuclear dye TOTO-3 (blue).
Overall, gland morphology is visualized with rhodamine-conjugated phalloidin
(red). Few cells in the posterior lobes (PL) of control gland show cyclin-B
staining, whereas PLs of the mutant glands are larger and show many cyclin-B-
positive cells (D). (E, F) Confocal images of control (E, lwr4-3/lwr4-3) and
mutant (F, lwr4-3/lwr4-3) hemocytes. None of the control hemocytes here are
cyclin-B-positive, whereas mutant cells in panel (F) show the presence of
cyclin B protein (arrow head).
Fig. 3. Suppression of the melanotic tumor phenotype. (A–D) Larvae with
melanotic tumors (white arrow) in mutant backgrounds. (A) lwr [c3-lwr14/
lwr5], (B) lwr dl [lwr14 Df(2L)TW119/lwr5 dl1], (C) lwr Dif [lwr14
Df(2L)TW119/C3 lwr5 Dif1], (D) lwr Dif dl[lwr14 Df(2L)TW119/C3
lwr5 Df(2L)J4]. (E–H) Hemocyte smears from control [lwr4-3/CyO y+] (E),
lwr [lwr4-3/lwr5] (F), lwr dl[lwr4-3 Df(2L)TW119/lwr5 dl1] (G), and
lwr Dif dl[lwr4-3 Df(2L)TW119/c3lwr5 Df(2L)J4] (H) larvae. White
arrows point to multinucleate cells (M), white arrowheads to lamellocytes (L),
black arrows to plasmatocytes (P), and black arrowheads to plasmatocytes
with abnormal nuclear morphology. Scale bars: E–G, 100 Am, H, 50 Am.
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GFP transgene) exhibit melanotic tumors (Table 1; Fig. 3D).
Consistent with this reduction in the penetrance of melanotic
tumors, the CHC and percentage lamellocyte values of triple
mutants were lower than those of lwr single mutants; the
reduction being statistically significant at days 6 and 8 after
egg lay (Supplementary Tables 1.4, 1.5; Figs. 3E, F, H). We
found that, while the percentage of lamellocytes relative to
total hemocytes in the single- and the triple-mutant back-
grounds remained at roughly 15% at day 6, a significant
reduction in lamellocyte percentage (4.97%) is observed in 8-
day-old triple mutants (Fig. 3H). These results suggest that the
Dorsal and/or Dif proteins play a critical role in mediating the
overproliferation and differentiation of hemocytes in the lwr
background. Mean CHC values of dl, Dif, dl Dif,
cactE10/cactD13, and cactE10/cactE8 mutants are statistically
indistinguishable from those of their respective internal
controls (Sorrentino, 2003; Sorrentino et al., 2004 and
unpublished results).
To determine whether loss of either Dorsal or Dif alone is
sufficient to suppress the hematopoietic defects of lwr, we next
compared hematopoietic defects of lwr4-3/lwr5 larvae with
those of lwr4-3 Df(2L)J4/lwr5 dl1 and lwr4-3 Df(2L)TW119/
lwr5 Dif1 double mutants. In general, we found that, while
there was some reduction in the melanotic tumor penetrance
and CHC in each of the double mutants, the suppression was
not as strong as when both loci were deleted (Table 1;
Supplementary Tables 1.4, 1.5). Deletion of dl led to a strongersuppression of melanotic tumors (Figs. 3A–C; Table 1),
whereas removal of Dif had a more significant effect in
suppressing CHC (Table 1; Supplementary Table 1.4). The
percentage of lamellocytes remains high in the double mutants
at both time points studied (Supplementary Table 1.5),
suggesting the possibility of a functionally redundant require-
ment of these NF-nB proteins in lamellocyte differentiation.
Suppression of hematopoietic defects by gain-of-function
cactusE10 allele
The CactusE10 protein lacks the N-terminal 144 amino acids,
it cannot undergo Toll signal-dependent degradation, and
therefore continues to retain Dorsal in the cytoplasm, even in
the presence of the signal (Bergmann et al., 1996). We took
advantage of this ‘‘gain-of-function’’ cactus allele to perform a
genetic epistasis experiment with lwr, as cactE10 and lwr
mutants exhibit opposite phenotypes. We found that melanotic
tumor penetrance was significantly reduced from greater than
90% in lwr4-3/lwr5 animals to less than 10% in lwr4-3 cactE8/
lwr5 cactE10 animals (Table 1). In 6-day-old larvae, the CHC
value of these double mutants was comparable to lwr4-3/lwr5
single mutants (Supplementary Table 1.4). However, by 8 days,
like the lwr dl and lwr Dif double mutants, CHC in lwr4-3
cactE8/lwr5 cactE10 double mutants is significantly reduced
(Supplementary Table 1.4). In contrast, the percentage of
lamellocytes in these double mutants remains high, and the
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Table 1.5). CHC of cactE10 mutants is statistically indistin-
guishable from their heterozygous controls (Qiu et al., 1998).
Constitutive expression of drosomycin in lwr mutants
To test the involvement of lwr in the activation of
antimicrobial genes, we crossed flies bearing GFP reporter
constructs for drosomycin, Cecropin A, diptericin, metchniko-
win, and attacin expression into the lwr5/lwr14 background
and examined GFP expression in the fat body of mutant larvae
in the absence of microbial infection (Figs. 4A–F). Because
lwr negatively controls hematopoietic proliferation via the
Toll–Dorsal pathway, we expected that dUbc9 protein might
have a similar, negative role in antimicrobial peptide activation
in the larval fat body.
Fat bodies and hemocytes (in circulation and in tumors) of
lwr5/lwr14 and lwr4-3/lwr5 larvae carrying the drosomycin-
GFP reporter showed strong GFP expression (Figs. 4B, G,
N), whereas lwr5/lwr14 carrying the Cecropin A-GFP reporter
showed lower GFP expression in the fat body but strong GFP
expression in the proventriculus region (Fig. 4C). Some
hemocytes of lwr4-3/lwr5 larvae in circulation (drom-GFP not
shown; Cec-GFP, Fig. 4M) and within tumors (drom-GFP;
Fig. 4N) were also GFP-positive. Cells of lwr mutant fat
bodies with the drom-GFP reporter become GFP-positive
during late third instar (5–6 days after egg lay) and become
more intensely fluorescent as animals get older. In contrast,
lwr5/lwr14 larvae carrying antibacterial diptericin-GFP,Fig. 4. lesswright regulates drosomycin activation in the larval fat body. (A–L) F
within different genetic backgrounds in the absence of immune challenge. (A) Unc
lwr5/lwr14 larvae with GFP reporters under the control of drosomycin (B), cecropin A
GFP expression in unchallenged lwr4-3/lwr5 mutant larvae as compared to controls (
(H), hopTum-l/Y; drom-GFP/+ (I). (J–L) Unchallenged drom-GFP expression in lwr4
Df(2L)J4/lwr5 dl1 (J), drom-GFP lwr5 Dif1/drom-GFP lwr14 Df(2L)J4 (K), dro
hemocytes from lwr4-3/lwr5 animals with the CecA-GFP (M) or in tumors with thmetchnikowin-GFP, or attacin-GFP reporters did not show
significant constitutive GFP expression in larval tissues (Figs.
4D–F). As expected, fat bodies of larvae carrying a gain-of-
function Toll allele (Toll10b/+) exhibit constitutive upregula-
tion of the drom-GFP reporter (Fig. 4H; Ferrandon et al.,
1998), whereas fat bodies of unchallenged lwr+ (Fig. 4A) or
hopTum-l/Y larvae (Fig. 4I) do not.
To confirm these GFP-reporter-based results, we performed
Northern blot analysis on RNA from control (lwr14/CyO y+ or
lwr5/CyO y+) and experimental (lwr5/lwr14) animals. The
Northern blot was hybridized with probes specific for
drosomycin and Cecropin A (Fig. 5A). Signals on the blot
were normalized relative to rp49 RNA, and the degree of
expression was then standardized relative to the RNA levels in
the challenged and unchallenged control animals (Fig. 5B). We
found that drosomycin expression was more than 25-fold
greater and Cecropin A expression was 14-fold greater in lwr
mutants than unchallenged control animals (Fig. 5A, lanes 1–
3; Fig. 5B, lane 3). Similarly, drosomycin expression was more
than double that of immune challenged control animals in the
lwr mutant background, while Cecropin A was about one third
as compared to controls (Figs. 5A and B, lanes 3 and 7). Thus,
like that of the GFP reporter transgenes, the expression of the
endogenous antimicrobial peptide genes is negatively regulated
by dUbc9 protein in the larval fat body.
To determine if constitutive drom-GFP reporter expression
is dependent on activities of Dorsal and/or Dif, we examined
animals carrying the reporter gene and mutations in lwr and dl
(drom-GFP lwr14 Df(2L)J4/lwr5 dl1), lwr and Dif (drom-GFPluorescent images of larvae showing various reporter GFP expression patterns
hallenged drom-GFP larvae (lwr+) do not express GFP. (B–F) Unchallenged
(C), diptericin (D), metchnikowin (E), and attacin (F) promoters. (G– I) drom-
see Materials and methods): lwr4-3/drom-GFP lwr5 (G), drom-GFP/+; Toll10b/+
-3/lwr5 double or triple mutants (lwr with dl and/or Dif): drom-GFP lwr14
m-GFP lwr5 Df(2L)J4/lwr14 Df(2L)TW119 (L). (M, N) GFP expression in
e drom-GFP reporter (N).
Fig. 5. Northern blot analysis of drosomycin and cecropin A1 expression in lesswright mutants. (A) Genotypes of animals used in the experiment are listed above the
gel: lane 1, non-immune-challenged w1118/w1118; lane 2, lwr14/+ or lwr5/+; lane 3, lwr5/lwr14; lane 4, drom-GFP lwr14 Df(2L)J4/lwr5 dl1; lane 5, drom-GFP lwr5
Df(2L)J4 lwr14/Df(2L)TW119; lane 6, drom-GFP Dif1 lwr5/drom-GFP lwr14 Df(2L)J4; lane 7, immune-challenged w1118/w1118. Hybridization probes used are
shown to the left. rp49 probe was used as a load control to quantify relative levels of RNA. (B) Relative levels of RNA quantified (relative to those observed in
bacterially challenged animals or unchallenged controls) were determined by Phosphoimager (see Materials and methods). Values shown here confirm the visual
observations of strong constitutive drosomycin expression in lwr backgrounds and its suppression in dl Dif background.
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(drom-GFP lwr5 Df(2L)J4/lwr14 Df(2L)TW119) under a
fluorescence microscope. We found that the expression of the
drom-GFP reporter gene is weaker in double or triple mutant
backgrounds than in lwr mutants (Figs. 4J–L), suggesting that
regulation of drosomycin activation by dUbc9 is dependent on
the activities of the Dorsal and Dif. A similar suppression of
drosomycin expression was observed in the Northern analysis
of the double and triple mutant animals. Constitutive droso-
mycin expression was partially suppressed when either one of
the Rel proteins was absent in the lwr mutant larvae but
completely suppressed in the absence of both Rel proteins
Dorsal and Dif (Fig. 5A, lanes 4–6; Fig. 5B). This pattern of
suppression was also observed for Cecropin A expression.
However, the apparent differences in transcription levels of
drosomycin and cecropin in the double mutant background
lacking Dorsal as compared to double (lacking Dif) and triple
mutant backgrounds (lacking both Rel proteins) are not known
(Figs. 5A and B, lanes 4–6). Together, these results confirm
that Dorsal and Dif are functionally redundant for drosomycin
activation in the larval fat body (Manfruelli et al., 1999;
Rutschmann et al., 2000).
Expression of wild-type dUbc9 protein, via the collagen-Gal4
promoter, partially rescues mutant phenotypes
To examine if the mutant phenotypes described here arise
solely due to a lesion in lwr and if tissue-specific phenotypes
can be rescued by tissue-specific expression of a lwr transgene,
we expressed wild-type dUbc9 protein in larval fat body and
hemocytes via Cg-GAL4 > UAS-lwrwt (see Materials and
methods). We compared phenotypes of mutant males withoutthe UAS-lwrwt transgene (yw/Y; lwr4-3 drom-GFP/lwr5 Cg-
GAL4) with those of mutant females carrying both components
of the expression system (yw UAS-lwrwt/yw; lwr4-3 drom-GFP/
lwr5 Cg-GAL4) and therefore expressing dUbc9 in fat body
and hemocytes. Three phenotypes monitored were (a) devel-
opmental delay, (b) drom-GFP expression (Figs. 6A–E), and
(c) melanotic tumor penetrance.
At day 4, animals in all genotypic classes were in larval
stages. By day 6, animals in the heterozygous classes
underwent pupariation following the normal developmental
program, and almost all animals monitored pupariated (n >
200). Mutant males, on the other hand, showed developmental
delay characteristic of this genotype, and 25% of the males
underwent pupariation only on day 8 (n = 36). In contrast,
more than 50% of the mutant females with one copy of the
dUbc9 transgene showed pupariation by day 7 (n = 53), and
their number increased to 61% by day 8 (n = 49). These
differences in rescue are statistically significant at both time
points (z test < 0.0002).
In the same experiment, rescue of constitutive drom-GFP
expression was monitored in animals 4–7 days after egg lay.
We examined GFP fluorescence in the entire organ of every
intact larva and also estimated the percentage of cells that were
GFP-positive. The spatial patterns of GFP-positive cells
observed were sporadic and varied in total number (Figs. 6B
and C). Thus, we further categorized the larva into groups
based on total percentage of GFP-positive cells. We did not
observe a significant difference in GFP fluorescence in animals
on days 4 and 5; most animals were GFP-negative or GFP-
positive in less than 10% of the fat body (Fig. 6E). However,
on days 6 and 7, more than 70% of mutant males (Figs. 6A; E,
n = 37, both days) showed clear fluorescence throughout the
Fig. 6. Rescue of drom-GFP expression. (A–C) Fluorescence visualized from drom-GFP expression through the larval cuticle. (A) Photograph of a 6-day-old male
that is GFP-positive in more than 80% of the fat body cells. (B–C) Photographs of 6-day-old female larvae that are GFP-positive in 11–50% of fat body cells (B) or
in less than 10% of all cells (C). (D) Fat body dissected from a 7-day-old female larva, 11–50% of whose cells are GFP-positive. (E) Bar graphs indicating
proportions of yellow mouth hook (YMH) males [yw/Y; lwr4-3 drom-GFP/lwr5 Cg-GAL4] or YMH females [yw UAS-lwrwt/yw; lwr4-3 drom-GFP/lwr5 Cg-GAL4],
4–7 days after egg lay, with fat body in which drom-GFP transgene is variably expressed. Different bar shades represent classes of larvae as a percentage of GFP-
positive cells as indicated. Total numbers of larvae scored (n) are shown above each bar.
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contrast, the fat bodies of less than 30% of females (Figs. 6B–
D; Fig. 6E, n = 46 for day 6, and n = 24 for day 7) showed
clear fluorescence with the majority of larvae containing GFP-
positive cells in less than 10% of the fat body. The observed
differences in fluorescence between male and female siblings at
each time point are statistically significant (z test < 0.0002).
No clear difference in the penetrance of melanotic tumors in
the two larval classes was observed (data not shown). One
reason for this result could be that the Cg promoter is not
expressed at high levels in lamellocytes of lwr mutants
(Kalamarz and Govind, unpublished results).
Discussion
Loss of dUbc9 function results in pleiotropic effects
Genetic experiments in Drosophila emphasize the central
regulatory role for Ubc9 function and sumoylation in different
cells and during different life cycle stages. lwr adults exhibit
defects in eye, wing, and leg morphogenesis, mutant males die
and the few surviving females are sterile, revealing roles fordUbc9 in cell division and differentiation, in tissue patterning,
and in oogenesis. In this paper, we describe additional defects
in dUbc9 mutants, based on our studies of mutant larvae. We
describe phenotypes that point to the involvement of dUbc9 in
larval metamorphosis, proliferation, and differentiation of
hematopoietic precursors, in antimicrobial gene expression,
and in NF-nB signal transduction. Our observations show that
these diverse biological processes share a common regulatory
mechanism involving sumoylation and the variety of the
phenotypes observed suggest the possibility of multiple
biochemical targets in vivo. Drosophila is an excellent model
for the identification of cell- and tissue-specific sumoylation
targets of Ubc9, and it is very likely that their conserved
mammalian counterparts will be similarly modified and
regulated.
Like many larval lethals (e.g., cact mutants, Qiu et al.,
1998), mutations in dUbc9 result in a prolonged third instar
period followed by larval death. Hematopoietic defects are
observed as early as 4 days after egg lay, whereas the immune
defects are evident 6 days after egg lay. Defects of both types
become severe as mutant animals persist in larval stages even
10 days after their birth. Indeed, constitutive expression of
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lwr4-3/lwr5 pupae and adults (data not shown). How dUbc9
affects the rate of development is currently not known.
Epistasis experiments between lwr and mutants of the
ecdysone genetic hierarchy may reveal a role for dUbc9
sumoylation during development and metamorphosis. Also not
known is whether hemocyte survival or their apoptosis is
affected in lwr mutants. One study of salivary gland apoptosis
in Drosophila during pupariation provides evidence that the
Rel family members are not required for salivary gland cell
death during metamorphosis (Lehmann et al., 2002). Our
results provide a link between lwr negative regulation of dl
and Dif in the larval fat body and hematopoietic tissues. In any
case, the hematopoietic and immune defects in lwr mutants
may be tied to abnormalities in larval development as these
defects are most pronounced in older animals. The rescue of
the immune defects by expression of the dUbc9 protein in the
fat body suggests that the misregulation of drom expression in
lwr mutants is due to a specific reduction or an absence of the
Ubc9 function. Analysis of mutant clones in the fat body or
lymph gland will reveal if the requirement of this enzyme is
cell autonomous or not.
Involvement of Ubc9 and NF-jB proteins in larval
hematopoiesis
Four distinct hematopoietic defects affecting hemocyte
abundance, differentiation, and morphology are observed in
both the lymph gland and circulating hemocyte populations in
4-day-old lwr larvae. The mean CHC values in mutants are
significantly higher than those of the pooled control class of
larvae; in two of the three lwr genetic combinations studied,
this increase in abundance correlates with an increase in
cyclin-B-positive hemocytes. Such increase in cyclin B-
positive hemocyte population is reminiscent of increase in
the B type cyclins in mutant yeast lacking Ubc9 (Seufert et al.,
1995). Our observations suggest that dUbc9 negatively
regulates the rate at which hematopoietic cells divide. The
prehemocyte classes influenced by the dUbc9 mutation are not
known, however, it is interesting that while there is an increase
in circulating plasmatocyte and lamellocyte percentages, there
is a clear reduction in the number of crystal cells. The opposite
effect of lwr on crystal cell numbers indicates a distinct role
for dUbc9 function in this hemocyte lineage. Prohemocytes
following the crystal cell fate require a combination of signals
from the transcription factors Serpent (Srp; human GATA-2)
and Lozenge (lz; human AML-1), along with permissive
signals from Ser/Notch (Lebestky et al., 2000, 2003). Perhaps
dUbc9 asserts a role in crystal cell development by propagat-
ing the above required signals or alleviating suppression of
this cellular fate exerted by the combinatorial interaction of
SrpNC (Srp isoform containing both N- and C-terminal Zinc
finger domains) and the U-shaped protein (Fossett et al.,
2003). These observations suggest multiple requirements for
dUbc9 in the hematopoietic tissue. Furthermore, as mitotic
defects are observed in both lymph gland hemocytes and
circulating hemocytes, and as these groups of hemocytesoriginate independently (Holz et al., 2003), it is likely that
dUbc9 function is independently required in each hemocyte
population.
The presence of large numbers of lamellocytes accounts for
a significant fraction (10–20%) of the increase of CHC in lwr
mutants. The coincident expansion of the plasmatocyte
population and constitutive differentiation of lamellocytes are
hallmarks of melanotic tumor mutants in which affected genes
are not necessarily related by either structure or function
(Evans et al., 2003 for recent review). Yet, hemocyte
proliferation and differentiation have distinct genetic require-
ments. For example, while the Drosophila kinase Hopscotch
and transcription factor STAT92E are required for lamellocyte
differentiation, Toll and Tube proteins are not, even though
upregulation of either the JAK/STAT or the Toll/NF-nB
pathways results in the production of melanotic tumors
(Sorrentino et al., 2004). One explanation for the simultaneous
expansion of the plasmatocyte and lamellocyte populations in
melanotic tumor mutants such as lwr, cact, and Toll10b is that
these mutations affect proliferation of precursors in the lymph
gland (or in circulation) that differentiate as plasmatocytes or
lamellocytes.
The aberrant nuclear morphologies observed in lwr4-3/lwr14
and lwr4-3/lwr5 hemocytes are variable in appearance and fall
into four categories: aneuploidy, abnormal nuclear shapes,
presence of multiple nuclei, and presence of fragmented
nuclear material (additional smaller Hoechst-positive struc-
tures). Genetic evidence suggests that dUbc9 is required for the
proper disjunction of homologous chromosomes in meiosis I
(Apionishev et al., 2001). It is thus possible that dUbc9 is also
involved in chromosome segregation in mitotic divisions.
Indeed, defects in lwr hemocytes are strikingly similar to
proliferation defects in cultured chicken cells conditionally
depleted of Ubc9 protein, in which cells with multiple or
fragmented nuclei are also observed (Hayashi et al., 2002). The
defects in chicken cells arise due to chromosomal loss during
chromosome segregation. In both Drosophila and chicken, the
frequency of cells with multiple or fragmented nuclei increases
with age (Hayashi et al., 2002 and our unpublished observa-
tions). Thus, it is possible that the biochemical targets of Ubc9
in chromosome segregation in Drosophila and chicken cells
(and possibly other vertebrates) are conserved and that
chromosomal damage accumulates in Ubc9-depleted cells
because of similar molecular processes. The proportion of
multinucleate hemocytes (in lwr4-3 larvae) is reduced in lwr4-3
dl as well as lwr4-3 Dif dl mutant larvae (Figs. 3F–H,
Chiu and Govind, unpublished observations). The identity of
the extra chromosomes and extrachromosomal DNA (small
dots, Fig. 1I) in dUbc9 mutant hemocytes is not known nor the
specificity of this phenotype to lwr allele 4-3. The presence of
multinucleate hemocytes in circulation within hemocyte over-
proliferation mutants is unique to lwr and, to date, has not been
reported in other mutants where similar overproliferation and
lamellocyte differentiation defects have been documented (e.g.,
hopTum-l, Harrison et al., 1995; Toll10b/+, Lemaitre et al., 1995;
cactus, Qiu et al., 1998), reflecting the multiplicity of effects
of dUbc9 on the cell cycle.
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presented here constitute the first clear evidence of a role for
Dorsal and Dif during hemocyte proliferation in Drosophila
larvae, even though these functions were predicted from
previous experiments (Govind, 1996; Qiu et al., 1998). Like
Cactus, the cellular function of dUbc9 is to regulate the nuclear
localization of NF-nB proteins. Interestingly, Dorsal and Dif
appear to have somewhat redundant functions as suppression
of lwr phenotypes is stronger in triple mutants than in double
mutants and suppression appears earlier in development in
triple mutants than in double mutants. Functional redundancy
may also explain why clear hematopoietic phenotypes (e.g.,
lowered hemocyte concentration or reduced encapsulation of
wasp egg) have not been observed in dl or Dif single mutants
(Sorrentino, 2003; Sorrentino et al., 2004). Similar redundancy
in Dorsal and Dif function has been reported for antimicrobial
peptide gene activation in the larval fat body (Manfruelli et al.,
1999).
dUbc9 is a negative regulator of drosomycin activation
Genetic experiments here support a model for negative
regulation by dUbc9 of antifungal peptide-encoding genes
drosomycin and Cecropin, making it the second negative
regulator of the Toll pathway to be identified so far. In
general, the effects of lwr mutants on drosomycin expression
are stronger than on that of Cecropin. These effects are
evident by our characterization using promoter-driven GFP
reporters representative of the Toll and Imd downstream
antimicrobial genes and subsequent confirmation by Northern
analysis in whole animals (see Figs. 4A–F; 5). Perhaps the
expression pattern of Cecropin A observed in lwr mutants is
partially independent of the Toll pathway. As previously
demonstrated, cecropin A is regulated by both Toll and Imd
immunity pathways (Lemaitre et al., 1996). Indeed, dynamic
expression patterns of the two variant Cec A1 and A2
transcripts are detected in adult flies, after specific microbial
infection regiments, further delineating their expression into
the two immune pathways (Hedengren-Olcott et al., 2004). A
detailed analysis of Cecropin A regulation in lwr mutant
larvae in combination with loss of function alleles of the Imd
pathway may elucidate control of this gene further.
The constitutive activation of drosomycin and Cecropin in
lwr mutants is also dependent on Dorsal and Dif, whose roles
and functional redundancy in the larval fat body are already
recognized (Manfruelli et al., 1999; Rutschmann et al., 2000).
Furthermore, genetic epistasis experiments described here
place dUbc9 function upstream of Dorsal/Dif and Cactus.
Our observations are largely consistent with previous bio-
chemical experiments on these proteins (Bhaskar et al., 2000,
2002) and provide additional support for a model in which
Dorsal, Dif, Cactus and dUbc9 exist in a complex that is
activated by a Toll-dependent signal. Significantly, however,
our results suggest that dUbc9 blocks the nuclear localization
of Dorsal and Dif and differ from observations made in
Drosophila S2 cell cultures, in which dUbc9 facilitates the
nuclear localization of Dorsal-GFP (Bhaskar et al., 2000,2002). This divergence in experimental results is likely to be
due to different experimental models used in the two studies.
Our genetic results are consistent with Ubc9’s role in InB
sumoylation and downregulation of the mammalian NF-nB
pathway (Hay et al., 1999). Consistent with this model of
mammalian Ubc9 function, it is likely that sumoylation of
Cactus by dUbc9 protects it from phosphorylation, assisting the
retention of Dorsal/Dif in the cytoplasm. This model requires
biochemical support as Cactus sumoylation has not been
demonstrated.
The intracellular Toll–Dorsal/Dif pathways in both the fat
body and in hemocytes include Toll, Tube, Pelle, Ubc9,
Dorsal, and Dif, and in both cases, dUbc9 appears to
function upstream of Cactus and Dorsal/Dif. Our observa-
tions with GFP reporter constructs suggest that the effect of
dUbc9 is restricted to the Toll pathway and it is possible
that the Imd signaling cascade is not regulated by sumoyla-
tion. Indeed, a ubiquitin proteasome pathway involving
function of SkpA and Slimb has been identified and shown
to repress the Imd pathway (Khush et al., 2002). Thus,
sumoylation and ubiquitination of specific targets appear to
have parallel but specific effects in downregulating these
pathways.
In conclusion, we present strong evidence that dUbc9 is a
negative regulator of the Toll-NF-nB pathways that control
both the humoral and cellular aspects of immune responses in
Drosophila. Spatzle activates the Toll pathway in the fat body;
however, a role for Spatzle function in hemocyte proliferation
or differentiation has not been demonstrated, and therefore the
mechanism of Toll activation in the hemocytes is not known.
Similarly, target genes of the NF-nB pathway in hemocytes
(besides the antimicrobial peptide genes) have not yet been
identified. The differences in phenotypes observed in lwr and
cact mutants are likely to arise from differences in gene
expression programs in the two mutants. These differences
provide a unique opportunity to resolve issues of biological
specificity in the regulation of NF-nB activation and gene
expression in vivo.
Note added in proof
Similar results were reported by Huang et al., 2005. Dev.
Biol. 280 (2), 407–420.
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